IO Biotech, Inc. (IOBT)

SEC fundamentals · as filed in 10-Q FY2025, period ended Sep 30, 2025 · updated Oct 7, 2026

Other listed symbols of this issuer: IOBTQ

Verified against EDGAR
Total Assets
$40.0M
Stockholders' Equity
$911,000
Cash & Equivalents
$30.7M
Long-Term Debt
$16.7M

as filed in 10-Q FY2025, period ended Sep 30, 2025 · View filings on EDGAR ↗

In its 10-Q for the period ended Sep 30, 2025, IO Biotech, Inc. reported net income of -$8.4M and total assets of $40.0M. Every figure below is taken directly from IO Biotech, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2024—-$95.5M
FY2023—-$86.1M
FY2022—-$71.5M
FY2021—-$67.9M
FY2020—-$12.0M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KMar 31, 2026on EDGAR ↗
8-KFeb 13, 2026on EDGAR ↗
8-KJan 30, 2026on EDGAR ↗
8-KJan 21, 2026on EDGAR ↗
8-KDec 19, 2025on EDGAR ↗
8-KNov 21, 2025on EDGAR ↗
8-KNov 18, 2025on EDGAR ↗
8-KNov 14, 2025on EDGAR ↗
10-QNov 14, 2025on EDGAR ↗
8-KSep 29, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2025 · 10-Q

Total Assets$40.0Msource ↗
Stockholders’ Equity$911,000source ↗
Cash & Equivalents$30.7Msource ↗
Long-Term Debt$16.7Msource ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2025

Revenue—source ↗
Net Income-$8.4Msource ↗
Operating Income-$19.4Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$13.7Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2025

EPS (diluted)$-0.13source ↗
EPS (basic)$-0.13source ↗
Shares Outstanding71.9Msource ↗
Cash from Operations-$18.5Msource ↗
Cash from Financing$21.3Msource ↗
Cash from Investing-$4,000source ↗

Restatement history

Point-in-time

No material restatements detected across 112 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches IOBT’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/IOBT

MCP tool: get_sec_fundamentals ticker=IOBT

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/IOBT/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=IOBT as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/IOBT/history

MCP tool: get_fundamentals_history ticker=IOBT

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/IOBT

MCP tool: get_financial_health ticker=IOBT

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.